Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints
Open Access
Abstract
Background: Discovering clinically useful molecular markers for predicting the survival of patients diagnosed with non–muscle-invasive bladder cancer can provide insights into cancer dynamics and improve treatment outcomes. However, the presence of competing risks (CR) endpoints complicates the estimation and inferential framework. There is also a lack of statistical analysis tools and software for coping with the high-throughput nature of these data, in terms of marker screening and selection. Aims: To propose a gene screening procedure for proportional subdistribution hazards regression under a CR framework, and illustrate its application in using molecular profiling to predict survival for non-muscle invasive bladder carcinoma. Methods: Tumors from 300 patients diagnosed with bladder cancer were analyzed for genomic abnormalities while controlling for clinically important covariates. Genes with expression patterns that were associated with survival were identified through a screening procedure based on proportional subdistribution hazards regression. A molecular predictor of risk was constructed and examined for prediction accuracy. Results: A six-gene signature was found to be a significant predictor associated with survival of non–muscle-invasive bladder cancer, subject to competing risks after adjusting for age, gender, reevaluated WHO grade, stage and BCG/MMC treatment (p-value < 0.001). Conclusion: The proposed gene screening procedure can be used to discover molecular determinants of survival for non–muscle-invasive bladder cancer and in general facilitate high-throughput competing risks data analysis with easy implementation.Keywords
Funding Information
- United States National Institutes of Health (NIH) (P20CA252717, P20CA264067, R01DE031134, R21DE031879, P30CA016059)
- VCU Quest fund (P20CA252717, P20CA264067, R01DE031134, R21DE031879, P30CA016059)
- NIH-NCI Cancer Center (P20CA252717, P20CA264067, R01DE031134, R21DE031879, P30CA016059)
This publication has 45 references indexed in Scilit:
- Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2012
- Feature Screening via Distance Correlation LearningJournal of the American Statistical Association, 2012
- The Use and Interpretation of Competing Risks Regression ModelsClinical Cancer Research, 2012
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerMolecular Cancer, 2011
- MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationMolecular Cancer, 2011
- Etiologic role of human papillomavirus infection in bladder carcinomaCancer, 2010
- Sure Independence Screening for Ultrahigh Dimensional Feature SpaceJournal of the Royal Statistical Society Series B: Statistical Methodology, 2008
- Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation StudyClinical Cancer Research, 2007
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988